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Persistent infection with oncogenic human papillomavirus (HPV) genotypes is a necessary cause of anogenital cancer and HPV infections account for more 
than 50% of infection-linked cancers in women worldwide. The immune system controls, at least partially, viral infection and subsequent tumor 
development. Around 90% of HPV-infected women will clear the virus within two years. However, it remains unclear which immune cells are implicated in 
this process and no study has been performed evaluating the direct interaction between HPV and NK cells although these cells play a key role in host 
resistance to virus and tumor. Since HPV cannot grow in vitro, virus-like particles (VLP) were used as a model for studying the NK cell response against the 
virus. Interestingly, NK cells displayed a higher cytotoxic activity and cytokine production  (TNF-α and IFN-γ) in the presence of HPV-VLP. Uptake of HPV-
VLP by dendritic cells (DC) has been shown to induce their activation, therefore, we investigated whether the stimulation of NK cell activity is linked to VLP 
internalization. We observed a faster entry into these cells compared to DC. Furthermore, virus uptake by NK cells is mediated by macropinocytosis, 
whereas this entry is dependent of clathrin or caveolin endocytosis pathways in DC. Using NK cell lines expressing or not CD16 and blocking antibody, we 
demonstrated that CD16 is necessary for HPV-VLP internalization, but also for degranulation and cytokine production. 
2. Rapid HPV-VLP internalization in CD16+ NK cells
Conclusions
- NK cell infiltration in HPV-associated lesions (data not 
shown)
- HPV-VLP induce cytotoxic activity and  cytokine secretion by 
CD16+ NK cells. 
- CD16 is necessary for HPV-VLP entry by macropinocytosis 
and NK activation. 
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1. HPV-VLP induce cytotoxic activity  and cytokine 
release by NK cells
Fig 2.1: VLP were coupled with 
CFSE and the fluorescence is 
emitted after VLP entry by cleavage 
of the CFSE by intracellular serine 
esterases. (A) Entry kinetic in NK 
and CasKi cells. (B) Comparison of 
VLP entry after 10 min in NK and 
DC from the same donor.
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Fig 2.2: Confocal and electron 
microscopy of  (A-E,G-H) NK cells  (B) 
CasKi and (C, F) DC,  arrow = HPV16-
VLP
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3. HPV-VLP uptake in NK cells is mediated by 
macropinocytosis
Fig 1.1 (A) Ratio of degranulation in NK cells in the presence of HPV16-
VLP, anti-CD16 mAb, a lysate of insect cells infected with WT baculovirus 
(WT) after 1h or 6 h of incubation (means ± SE, n>3). (B) NK cells 
cytotoxic against CasKi cell line in 10 h 51Cr release assay (n = 4), (C) 
TNF-α  and (D) IFN-γ ELISA assays (means ± SE, n≥3, * p<0.05).
Fig 3.1: (A) FITC-Dextran 
uptake in NK cells (means ± 
SE of f luorescence fo ld 
increase over the control 
condition, n=3). (B-C) GTPase 
assays of (B) Cdc42 and of (C) 
Rac1 on NK cells (1 of 3 
independent experiments) (D) 
The percentages of VLP entry 
inhibition in presence of 
chlorpromazine, nystatine and 
cytochalasin, respectively 
i n h i b i t o r o f c l a t h r i n e , 
caveolaor macropinocytosis 
pathways (means ± SE, n = 
6-9; * p<0.05, ** p<0.005)
4. CD16 is required for rapid HPV16-VLP uptake 
and NK cell activation
Fig 4.1:  (A) Entry of CFSE HPV-VLP in NK92 CD16- (no CD16 expression),  NK92 
CD16+/-, NK92 CD16+ (means ± SE, n ≤ 3). (B-C) Confocal microscopy of CFSE 
HPV-VLP entry after 10 min of incubation into (B) the NK92 CD16+ or into (C) the 
NK92 CD16- cell line. (D) Lynx HPV-VLP internalization into NK cells with or 
without pre-incubation with an anti-CD16 antibody (n ≤ 3). (E) Lynx HPV16-VLP 
internalization into CD56+bright CD16- NK cells compared to CD56+dim CD16+ NK 
cells. 
Fig 4.2:  (A) Ratio of degranulation in NK92 CD16+ and NK92 CD16- cells 
(means ± SE, n>3), (B-C) NK92 CD16+ cells cytotoxic activity against CasKi cell 
line in a 10 h 51Cr release assay (n = 4), (D) TNF-α  and (E) IFN-γ ELISA assays 
on supernant of NK92 CD16+ and CD16- cells (means ± SE, n = 4; * p<0.05).
NK cells interact with HPV and could 
participate in the immune response against 
HPV-induced tumors. 
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